Clinical Trial Update: Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial evaluating lenalidomide and dexamethasone with or without bortezomib as initial treatment for patients with previo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: DS Stage I Multiple Myeloma, DS Stage II Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2017-07-06